Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Herman

Showing results (161-170 of 316) with videos related to

Pageof 32
Sort By:
Diagnostics (Basel, Switzerland)|December 23, 2022
Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future ApplicationsBen S Singh, Irina M Cazacu, Carlos A Deza, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinomaPablo E Serrano, Joseph M Herman, Kent A Griffith, et al.
Cancers|May 5, 2021
Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal ToxicityDaniel Lin, Shalini Moningi, Joseph Abi Jaoude, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2018
Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation TherapyZiwei Feng, Avani D Rao, Zhi Cheng, et al.
Cancer|September 22, 2011
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentSkye C Mayo, Hari Nathan, John L Cameron, et al.
Cancers|May 13, 2026
Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Early-Onset Pancreatic Cancer: Clinical Outcomes and ToxicityShuchi Sehgal, Abhinav V Reddy, Suqi Ke, et al.
Translational Oncology|December 15, 2010
A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancerWen Wee Ma, Joseph M Herman, Antonio Jimeno, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreasBoris Hristov, Sushanth Reddy, Steven H Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 28, 2012
Young patients undergoing resection of pancreatic cancer fare better than their older counterpartsJin He, Barish H Edil, John L Cameron, et al.
Journal of Surgical Oncology|February 2, 2011
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinomaMechteld C de Jong, Fuyu Li, John L Cameron, et al.
Pageof 32

Showing results (161-170 of 316) with videos related to

Sort By:
Pageof 32
Diagnostics (Basel, Switzerland)|December 23, 2022
Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future ApplicationsBen S Singh, Irina M Cazacu, Carlos A Deza, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinomaPablo E Serrano, Joseph M Herman, Kent A Griffith, et al.
Cancers|May 5, 2021
Development of an Objective Scoring System for Endoscopic Assessment of Radiation-Induced Upper Gastrointestinal ToxicityDaniel Lin, Shalini Moningi, Joseph Abi Jaoude, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2018
Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation TherapyZiwei Feng, Avani D Rao, Zhi Cheng, et al.
Cancer|September 22, 2011
Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intentSkye C Mayo, Hari Nathan, John L Cameron, et al.
Cancers|May 13, 2026
Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Early-Onset Pancreatic Cancer: Clinical Outcomes and ToxicityShuchi Sehgal, Abhinav V Reddy, Suqi Ke, et al.
Translational Oncology|December 15, 2010
A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancerWen Wee Ma, Joseph M Herman, Antonio Jimeno, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreasBoris Hristov, Sushanth Reddy, Steven H Lin, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 28, 2012
Young patients undergoing resection of pancreatic cancer fare better than their older counterpartsJin He, Barish H Edil, John L Cameron, et al.
Journal of Surgical Oncology|February 2, 2011
Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinomaMechteld C de Jong, Fuyu Li, John L Cameron, et al.
Pageof 32